• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    6/16/23 1:08:45 PM ET
    $AGRX
    $ASRV
    $AUVI
    $BLTE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Major Banks
    Finance
    Get the next $AGRX alert in real time by email

     

    Friday's session saw 32 companies set new 52-week lows.

    Key Facts About Today's 52-Week Lows:

    • Royalty Pharma (NASDAQ:RPRX) was the largest company by market cap to set a new 52-week low.
    • The smallest company by market cap to set a new 52-week low was Panbela Therapeutics (NASDAQ:PBLA).
    • Panbela Therapeutics (NASDAQ:PBLA) made the largest move down on the session, with shares plummeting 52.67% to reach its 52-week low.
    • Delaware Inv Natl Muni (AMEX:VFL) shares were the most resilient, as shares rose 0.0%, rebounding from its new 52-week low.

    The stocks that set new 52-week lows on Friday:

    • Royalty Pharma (NASDAQ:RPRX) stock hit a new 52-week low of $31.68. The stock was down 0.68% on the session.
    • Cava Group (NYSE:CAVA) stock drifted down 10.35% on Friday morning to hit a new 52-week low of $36.60.
    • Chijet Motor Co (NASDAQ:CJET) stock hit a yearly low of $2.69. The stock was down 18.89% for the day.
    • Duff & Phelps Utility (NYSE:DPG) shares set a new yearly low of $10.31 this morning. The stock was down 17.67% on the session.
    • Belite Bio (NASDAQ:BLTE) stock dropped to a yearly low on Friday of $13.30. Shares traded down 4.95%.
    • Canopy Gwth (NASDAQ:CGC) shares were down 1.04% for the day, having made a 52-week low of $0.63.
    • Gold Royalty (AMEX:GROY) shares moved down 1.08% on Friday to hit a new 52-week low of $1.83, drifting down 1.08%.
    • Nutex Health (NASDAQ:NUTX) stock set a new 52-week low of $0.40 on Friday, moving down 1.89%.
    • Karyopharm Therapeutics (NASDAQ:KPTI) shares made a new 52-week low of $1.95 on Friday. The stock was down 0.48% for the day.
    • Tredegar (NYSE:TG) stock hit a new 52-week low of $5.85. The stock was down 5.24% on the session.
    • 1stdibs.com (NASDAQ:DIBS) shares set a new yearly low of $3.44 this morning. The stock was down 2.22% on the session.
    • Delaware Inv Natl Muni (AMEX:VFL) shares made a new 52-week low of $9.89 on Friday. The stock was 0.0% (flat) for the day.
    • 22nd Century Group (NASDAQ:XXII) stock drifted down 2.16% on Friday morning to hit a new 52-week low of $0.47.
    • AmeriServ Financial (NASDAQ:ASRV) shares set a new 52-week low of $2.69. The stock traded down 1.81%.
    • Sensei Biotherapeutics (NASDAQ:SNSE) stock hit a new 52-week low of $1.25. The stock was 0.0% (flat) on the session.
    • Koss (NASDAQ:KOSS) stock achieved a new 52-week low on Friday morning, hitting $3.65 and moving down 3.17%.
    • MediaCo Holding (NASDAQ:MDIA) stock hit $0.98 on Friday morning, setting a new 52-week low for a change of down 0.75%.
    • Trio Petroleum (AMEX:TPET) shares reached a new 52-week low of $1.13 on Friday morning, moving down 8.8%.
    • Phoenix New Media (NYSE:FENG) shares moved down 3.72% on Friday to hit a new 52-week low of $2.05, drifting down 3.72%.
    • Hempacco (NASDAQ:HPCO) shares were down 1.92% for the day, having made a 52-week low of $0.44.
    • Universe Pharmaceuticals (NASDAQ:UPC) shares made a new 52-week low of $0.44 on Friday. The stock was down 34.94% for the day.
    • Precipio (NASDAQ:PRPO) shares moved down 2.14% on Friday to hit a new 52-week low of $0.42, drifting down 2.14%.
    • Plus Therapeutics (NASDAQ:PSTV) shares made a new 52-week low of $2.80 on Friday. The stock was down 1.64% for the day.
    • Bit Brother (NASDAQ:BTB) stock hit a yearly low of $0.56. The stock was down 8.31% for the day.
    • Energy Focus (NASDAQ:EFOI) shares moved down 18.85% on Friday to hit a new 52-week low of $0.27, drifting down 18.85%.
    • Applied UV (NASDAQ:AUVI) stock broke to a new 52-week low of $1.02 on Friday. Shares of the company traded down 42.63%.
    • Smart for Life (NASDAQ:SMFL) shares fell to $1.01 on Friday, setting a new 52-week low with a shift of down 6.43%.
    • Agile Therapeutics (NASDAQ:AGRX) shares fell to $3.03 on Friday, setting a new 52-week low with a shift of down 5.54%.
    • Panbela Therapeutics (NASDAQ:PBLA) stock hit a yearly low of $2.64. The stock was down 52.67% for the day.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $AGRX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGRX
    $ASRV
    $AUVI
    $BLTE

    CompanyDatePrice TargetRatingAnalyst
    Karyopharm Therapeutics Inc.
    $KPTI
    2/5/2026Overweight
    Cantor Fitzgerald
    CAVA Group Inc.
    $CAVA
    2/5/2026$80.00Buy
    The Benchmark Company
    PLUS THERAPEUTICS Inc.
    $PSTV
    2/3/2026$2.00Buy
    Lake Street
    Royalty Pharma plc
    $RPRX
    1/30/2026$49.00Neutral → Buy
    UBS
    Belite Bio Inc
    $BLTE
    1/26/2026$195.00Buy
    BofA Securities
    Gold Royalty Corp.
    $GROY
    1/22/2026Buy → Hold
    Canaccord Genuity
    CAVA Group Inc.
    $CAVA
    1/9/2026$85.00Outperform
    Telsey Advisory Group
    Belite Bio Inc
    $BLTE
    1/6/2026$191.00Overweight
    Morgan Stanley
    More analyst ratings

    $AGRX
    $ASRV
    $AUVI
    $BLTE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $AGRX
    $ASRV
    $AUVI
    $BLTE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Trio Petroleum Corp. Provides Alberta Operations Update and Confirms Near-Term Production Commencement

    Malibu, California, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Trio Petroleum Corp (NYSE:TPET) ("Trio" or the "Company"), an oil and gas company, through its wholly owned Canadian subsidiary, Trio Petroleum Canada, Corp. ("Trio Canada"), is pleased to provide an operational update on its Alberta heavy-oil asset located at NW 7-50-1W4, marking the Company's first producing foothold and strategic entry into the Province of Alberta. Trio confirms that, as of January 30, 2026, all required Alberta Energy Regulator ("AER") approvals and license transfers associated with the property were completed. With regulatory approvals now in place, Trio Canada has transitioned the asset from acquisition and regul

    2/5/26 8:00:00 AM ET
    $TPET
    Oil & Gas Production
    Energy

    Karyopharm to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

    -- Conference Call Scheduled for Thursday, February 12, 2026, at 8:00 a.m. ET -- NEWTON, Mass., Feb. 5, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (NASDAQ:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report fourth quarter and full year 2025 financial results on Thursday, February 12, 2026. Karyopharm's management team will host a conference call and audio webcast at 8:00 a.m. ET on Thursday, February 12, 2026, to discuss the financial results and other company updates. To access the conference call, please dial (800) 836-8184 (local) or (646) 357-8785 (international) at least 10 minutes prior to the start time and ask to b

    2/5/26 7:30:00 AM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CAVA to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

    CAVA Group, Inc. (NYSE:CAVA), the category-defining Mediterranean fast-casual restaurant brand that brings heart, health, and humanity to food, will host a conference call on Tuesday, February 24, 2026 at 5:00 PM Eastern Time to discuss fourth quarter and full year 2025 financial results and provide a business update. A press release with fourth quarter and full year financial results will be issued at approximately 4:10 PM Eastern Time on Tuesday, February 24, 2026. The call will be webcast live from the Company's website on the investor relations page at investor.cava.com. A recorded webcast will be available on CAVA's investor relations website shortly after the call and available fo

    2/4/26 4:10:00 PM ET
    $CAVA
    Restaurants
    Consumer Discretionary

    $AGRX
    $ASRV
    $AUVI
    $BLTE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on Karyopharm Therapeutics

    Cantor Fitzgerald initiated coverage of Karyopharm Therapeutics with a rating of Overweight

    2/5/26 6:58:02 AM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    The Benchmark Company initiated coverage on CAVA Group with a new price target

    The Benchmark Company initiated coverage of CAVA Group with a rating of Buy and set a new price target of $80.00

    2/5/26 6:56:49 AM ET
    $CAVA
    Restaurants
    Consumer Discretionary

    Lake Street initiated coverage on Plus Therapeutics with a new price target

    Lake Street initiated coverage of Plus Therapeutics with a rating of Buy and set a new price target of $2.00

    2/3/26 8:52:26 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    $AGRX
    $ASRV
    $AUVI
    $BLTE
    SEC Filings

    View All

    SEC Form S-3 filed by Canopy Growth Corporation

    S-3 - Canopy Growth Corp (0001737927) (Filer)

    2/6/26 4:15:52 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Canopy Growth Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Canopy Growth Corp (0001737927) (Filer)

    2/6/26 7:05:59 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 10-Q filed by Canopy Growth Corporation

    10-Q - Canopy Growth Corp (0001737927) (Filer)

    2/6/26 6:45:57 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    $AGRX
    $ASRV
    $AUVI
    $BLTE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP & CFO Coyne Terrance P. sold $10,360,814 worth of Class A Ordinary Shares (243,541 units at $42.54) (SEC Form 4)

    4 - Royalty Pharma plc (0001802768) (Issuer)

    2/4/26 5:07:40 PM ET
    $RPRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP, CFO & Treasurer Macomber Lori sold $10,244 worth of shares (1,626 units at $6.30), decreasing direct ownership by 2% to 85,105 units (SEC Form 4)

    4 - Karyopharm Therapeutics Inc. (0001503802) (Issuer)

    2/4/26 4:11:52 PM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP & Chief Commercial Officer Cheng Sohanya Roshan was granted 32,415 shares, increasing direct ownership by 41% to 111,921 units (SEC Form 4)

    4 - Karyopharm Therapeutics Inc. (0001503802) (Issuer)

    2/3/26 4:32:38 PM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGRX
    $ASRV
    $AUVI
    $BLTE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Operating Officer Sabet Ahmed Zaki bought $468 worth of shares (20 units at $23.40), increasing direct ownership by 2% to 1,015 units (SEC Form 4)

    4/A - Precipio, Inc. (0001043961) (Issuer)

    1/20/26 4:22:27 PM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: Chief Operating Officer Sabet Ahmed Zaki bought $488 worth of shares (25 units at $19.50), increasing direct ownership by 3% to 995 units (SEC Form 4)

    4/A - Precipio, Inc. (0001043961) (Issuer)

    1/20/26 4:21:46 PM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: Chief Operating Officer Sabet Ahmed Zaki bought $505 worth of shares (31 units at $16.30), increasing direct ownership by 3% to 970 units (SEC Form 4)

    4/A - Precipio, Inc. (0001043961) (Issuer)

    1/20/26 4:19:49 PM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AGRX
    $ASRV
    $AUVI
    $BLTE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13G/A filed by Gold Royalty Corp.

    SC 13G/A - Gold Royalty Corp. (0001834026) (Subject)

    11/15/24 4:37:48 PM ET
    $GROY
    Precious Metals
    Basic Materials

    Amendment: SEC Form SC 13G/A filed by Smart for Life Inc.

    SC 13G/A - SMART FOR LIFE, INC. (0001851860) (Subject)

    11/14/24 6:49:12 PM ET
    $SMFL
    Medicinal Chemicals and Botanical Products
    Health Care

    $AGRX
    $ASRV
    $AUVI
    $BLTE
    Leadership Updates

    Live Leadership Updates

    View All

    MediaCo Appoints Maire Mason to Lead Local Radio and Television Operations, Driving Major New York Market Shift

    Veteran Executive Joins MediaCo to Oversee NYC, Chicago, and Denver with Additional Expansion Planned MediaCo Holding Inc. (NASDAQ:MDIA) today announced the appointment of Maire Mason as Vice President and General Manager of Local MediaCo Markets, marking a significant leadership move in the New York radio and television landscape. In this role, Mason will oversee MediaCo's local radio and television operations across New York City, Chicago, and Denver, with responsibility for marquee brands including HOT 97 (WQHT-FM), WBLS-FM, Luna 107.5 (WBLS-HD2), La Buena (WQHT-HD2), and EstrellaTV's WMBC-TV in the New York tri-state area. MediaCo expects Mason's responsibilities to expand to additi

    1/26/26 8:00:00 AM ET
    $MDIA
    Broadcasting
    Consumer Discretionary

    GoldMining Appoints Martin Dumont as VP, Corporate Development and Investor Relations

    VANCOUVER, BC, Jan. 22, 2026 /PRNewswire/ - GoldMining Inc. (the "Company" or "GoldMining") (TSX:GOLD, NYSE:GLDG) is pleased to announce the appointment of Martin Dumont as Vice President, Corporate Development & Investor Relations. Alastair Still, President & Chief Executive Officer of GoldMining commented: "We are pleased to welcome Martin to the GoldMining team. His mining industry experience across corporate development, capital markets, and investor relations within the gold sector will play a key role as we continue to advance our portfolio and pursue value-accretive opp

    1/22/26 6:30:00 AM ET
    $GLDG
    $GROY
    $USGO
    Precious Metals
    Basic Materials

    CAVA Names Doug Thompson Chief Operations Officer to Lead Next Phase of Growth

    CAVA, the category-defining fast casual Mediterranean brand known for its bold, flavorful food and focus on heart-forward hospitality, today announced the appointment of Doug Thompson as Chief Operations Officer, effective March 2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112776328/en/CAVA COO, Doug Thompson In this role, Thompson will oversee CAVA's restaurant operations and field teams, helping the company deliver on its mission to bring heart, health, and humanity to food as it continues its rapid expansion across the country. Thompson is a veteran in the industry, spending over two decades at Texas Roadhouse, where

    1/12/26 4:00:00 PM ET
    $CAVA
    Restaurants
    Consumer Discretionary

    $AGRX
    $ASRV
    $AUVI
    $BLTE
    Financials

    Live finance-specific insights

    View All

    Karyopharm to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

    -- Conference Call Scheduled for Thursday, February 12, 2026, at 8:00 a.m. ET -- NEWTON, Mass., Feb. 5, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (NASDAQ:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report fourth quarter and full year 2025 financial results on Thursday, February 12, 2026. Karyopharm's management team will host a conference call and audio webcast at 8:00 a.m. ET on Thursday, February 12, 2026, to discuss the financial results and other company updates. To access the conference call, please dial (800) 836-8184 (local) or (646) 357-8785 (international) at least 10 minutes prior to the start time and ask to b

    2/5/26 7:30:00 AM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CAVA to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

    CAVA Group, Inc. (NYSE:CAVA), the category-defining Mediterranean fast-casual restaurant brand that brings heart, health, and humanity to food, will host a conference call on Tuesday, February 24, 2026 at 5:00 PM Eastern Time to discuss fourth quarter and full year 2025 financial results and provide a business update. A press release with fourth quarter and full year financial results will be issued at approximately 4:10 PM Eastern Time on Tuesday, February 24, 2026. The call will be webcast live from the Company's website on the investor relations page at investor.cava.com. A recorded webcast will be available on CAVA's investor relations website shortly after the call and available fo

    2/4/26 4:10:00 PM ET
    $CAVA
    Restaurants
    Consumer Discretionary

    Canopy Growth to Report Third Quarter Fiscal 2026 Financial Results on February 6, 2026

    Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED, NASDAQ:CGC) will release its financial results for the third quarter fiscal year 2026 ended December 31, 2025 before financial markets open on February 6, 2026. Following the release of its third quarter fiscal year 2026 financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO and Tom Stewart, CFO on February 6, 2026 at 10 AM Eastern Time (ET). Webcast Information A live audio webcast will be available at: https://onlinexperiences.com/Launch/QReg/ShowUUID=45C34153-5530-4D6A-A742-BC34AD2534FA Replay Information A replay will be accessible by webcast until 11:59 PM ET on May 7, 2026 at:

    1/23/26 7:00:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care